Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons - PubMed (original) (raw)

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons

Leonard Petrucelli et al. Neuron. 2002.

Free article

Abstract

One hypothesis for the etiology of Parkinson's disease (PD) is that subsets of neurons are vulnerable to a failure in proteasome-mediated protein turnover. Here we show that overexpression of mutant alpha-synuclein increases sensitivity to proteasome inhibitors by decreasing proteasome function. Overexpression of parkin decreases sensitivity to proteasome inhibitors in a manner dependent on parkin's ubiquitin-protein E3 ligase activity, and antisense knockdown of parkin increases sensitivity to proteasome inhibitors. Mutant alpha-synuclein also causes selective toxicity to catecholaminergic neurons in primary midbrain cultures, an effect that can be mimicked by the application of proteasome inhibitors. Parkin is capable of rescuing the toxic effects of mutant alpha-synuclein or proteasome inhibition in these cells. Therefore, parkin and alpha-synuclein are linked by common effects on a pathway associated with selective cell death in catecholaminergic neurons.

PubMed Disclaimer

Similar articles

• [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
  Corti O, Brice A. Corti O, et al. Med Sci (Paris). 2003 May;19(5):613-9. doi: 10.1051/medsci/2003195613. Med Sci (Paris). 2003. PMID: 12836396 Review. French.
• Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
  Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa A, L Dawson V, Dawson TM, Ross CA. Tanaka Y, et al. Hum Mol Genet. 2001 Apr 15;10(9):919-26. doi: 10.1093/hmg/10.9.919. Hum Mol Genet. 2001. PMID: 11309365
• [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
  Corti O, Brice A. Corti O, et al. J Soc Biol. 2002;196(1):95-10. J Soc Biol. 2002. PMID: 12134640 Review. French.
• Are ubiquitination pathways central to Parkinson's disease?
  Giasson BI, Lee VM. Giasson BI, et al. Cell. 2003 Jul 11;114(1):1-8. doi: 10.1016/s0092-8674(03)00509-9. Cell. 2003. PMID: 12859888 Review.
• Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
  Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ. Shimura H, et al. Science. 2001 Jul 13;293(5528):263-9. doi: 10.1126/science.1060627. Epub 2001 Jun 28. Science. 2001. PMID: 11431533

Cited by

• Integrating pathways of Parkinson's disease in a molecular interaction map.
  Fujita KA, Ostaszewski M, Matsuoka Y, Ghosh S, Glaab E, Trefois C, Crespo I, Perumal TM, Jurkowski W, Antony PM, Diederich N, Buttini M, Kodama A, Satagopam VP, Eifes S, Del Sol A, Schneider R, Kitano H, Balling R. Fujita KA, et al. Mol Neurobiol. 2014 Feb;49(1):88-102. doi: 10.1007/s12035-013-8489-4. Epub 2013 Jul 7. Mol Neurobiol. 2014. PMID: 23832570 Free PMC article. Review.
• Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.
  Exner N, Lutz AK, Haass C, Winklhofer KF. Exner N, et al. EMBO J. 2012 Jun 26;31(14):3038-62. doi: 10.1038/emboj.2012.170. EMBO J. 2012. PMID: 22735187 Free PMC article. Review.
• Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation.
  Outeiro TF, Klucken J, Strathearn KE, Liu F, Nguyen P, Rochet JC, Hyman BT, McLean PJ. Outeiro TF, et al. Biochem Biophys Res Commun. 2006 Dec 22;351(3):631-8. doi: 10.1016/j.bbrc.2006.10.085. Epub 2006 Oct 26. Biochem Biophys Res Commun. 2006. PMID: 17081499 Free PMC article.
• The impact of genetic research on our understanding of Parkinson's disease.
  Martin I, Dawson VL, Dawson TM. Martin I, et al. Prog Brain Res. 2010;183:21-41. doi: 10.1016/S0079-6123(10)83002-X. Prog Brain Res. 2010. PMID: 20696313 Free PMC article.
• Genetic determinants at the interface of cancer and neurodegenerative disease.
  Morris LG, Veeriah S, Chan TA. Morris LG, et al. Oncogene. 2010 Jun 17;29(24):3453-64. doi: 10.1038/onc.2010.127. Epub 2010 Apr 26. Oncogene. 2010. PMID: 20418918 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal